Multicentric Castleman ’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018

ConclusionThe most effective first-line therapy and retreatment option remains rituximab. The effectiveness of other treatment options like splenectomy or different immunotherapeutic approaches requires confirmation in larger-scale studies.
Source: Infection - Category: Infectious Diseases Source Type: research